Sign In
Buy ABVC
$1.01
-0.0700 (-6.48%)
At Close: Jul 31, 2026
ABVC BioPharma Selects Additional Vitargus® Phase II Study Site
12:30pm, Friday, 09'th Sep 2022 GlobeNewswire Inc.
New Australia Site Confirmed to Participate in the Study
Why Nikola Dropped Over 9%; Here Are 66 Biggest Movers From Yesterday
09:50am, Wednesday, 31'st Aug 2022 Benzinga
Gainers
Mobile Global Esports Inc. (NASDAQ: MGAM) shares surged 103.9% to settle at $5.30 on Tuesday. Shares are in low-float territory; the issue has about 15 million shares in its float.
NewAge, In
ABVC BioPharma Provides Vitargus® Update
12:30pm, Thursday, 18'th Aug 2022 GlobeNewswire Inc.
Phase II Vitargus® Clinical Trial Receives Local Ethics Committee Approval in Thailand
ABVC BioPharma Reports Second Quarter 2022 Financial and Operational Results
09:48pm, Monday, 15'th Aug 2022 GlobeNewswire Inc.
FREMONT, CA, Aug. 15, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC BioPharma, Inc. (Nasdaq: ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in oncology/hemat
ABVC Notes New Report That Estimates Global Retinal Surgical Instruments Market to Grow to $2.46 Billion by 2028
12:30pm, Monday, 18'th Jul 2022 GlobeNewswire Inc.
-- Growth to benefit ABVC’s Vitargus medical device product -- FREMONT, CA, July 18, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC Biopharma, Inc. (NASDAQ: ABVC), a clinical stage biopharmace
ABVC BioPharma Provides ADHD Phase II Part 2 Clinical Update
12:30pm, Wednesday, 13'th Jul 2022 GlobeNewswire Inc.
FREMONT, CA, July 13, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC Biopharma, Inc. (NASDAQ: ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in oncology/hemat
This Healthcare Stock is Down By More Than 50%: Here's 25 Stocks Moving Premarket
10:22am, Wednesday, 13'th Jul 2022 Benzinga
Gainers
Minim, Inc. (NASDAQ: MINM) rose 42.8% to $0.52 in pre-market trading. Minim recently said Nicole Hayward Zheng will be transitioning from her role as President and Chief Marketing Officer to
Stocks That Hit 52-Week Lows On Friday
04:05pm, Friday, 24'th Jun 2022 Benzinga
On Friday, 61 companies hit new 52-week lows.
Areas of Interest About Today's 52-Week Lows:
Ecopetrol (NYSE:EC) was the biggest company in terms of market cap to set a new 52-week low.
ThermoGenesis
ABVC BioPharma Submitted Vitargus® Phase II Study Plan to Australia HREC
12:30pm, Thursday, 16'th Jun 2022 GlobeNewswire Inc.
FREMONT, CA, June 16, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC Biopharma, Inc. (NASDAQ: ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in oncology/hemat
ABVC BioPharma Announces Termination of Two Contracts
12:30pm, Friday, 10'th Jun 2022 GlobeNewswire Inc.
FREMONT, CA, June 10, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC Biopharma, Inc. (NASDAQ: ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in oncology/hemat
ABVC BioPharma Announces Enrollment Progress for ADHD Phase II Part 2 Clinical Study
12:30pm, Wednesday, 01'st Jun 2022 GlobeNewswire Inc.
FREMONT, CA, June 01, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC Biopharma, Inc. (NASDAQ: ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in oncology/hemat
ABVC BioPharma Engaged by Orion BioTech to Identify Global Licensing Partners
12:30pm, Wednesday, 25'th May 2022 GlobeNewswire Inc.
FREMONT, CA, May 25, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC Biopharma, Inc. (NASDAQ: ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in oncology/hemato
Prestigious Researchers to Provide Consulting Services in Connection with ABVC BioPharma's Depression Medicines
11:30am, Monday, 23'rd May 2022 GlobeNewswire Inc.
Fremont, CA, May 23, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in oncology/hemat
ABVC Biopharma Reports First Quarter 2022 Financial and Operational Results
09:46pm, Monday, 16'th May 2022 GlobeNewswire Inc.
FREMONT, CA, May 16, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire--ABVC BioPharma, Inc. (Nasdaq: ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in oncology/hematolo
ABVC BioPharma Engages the FreeMind Group to Support Grant Funding
12:30pm, Friday, 13'th May 2022 GlobeNewswire Inc.
FREMONT, CA, May 13, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in oncology/hemato
